Aliases: DP2, DP3, DP2.5, PPP1R46.
APC is a large, multidomain tumor suppressor that coordinates beta-catenin turnover and cytoskeletal organization. Its central repeats bind beta-catenin and its SAMP motifs engage AXIN in the cytoplasmic destruction complex, helping recruit and present beta-catenin to kinases and ubiquitination machinery. Its C-terminal regions bind microtubules, associate with microtubule-end proteins and directly recruit actin monomers to nucleate filaments. These activities contribute to cell polarity, migration and accurate mitosis. APC also binds regulatory partners, including Asef-family nucleotide-exchange factors, whose autoinhibition it can relieve. APC occupies cytoplasmic, cortical, junctional and nuclear pools; truncating variants disrupt several of these separable functions and underlie familial adenomatous polyposis and many sporadic colorectal cancers.
Relationship is the entry's genetic[].relationship_type. untyped means the entry has a genetic record for the gene but does not type it; its free-text association is shown instead.
| Disorder | Relationship | Where the gene appears |
|---|---|---|
| Desmoid Tumor | causative germline |
mechanism: Constitutive Activation of the Wnt-beta-catenin Axis; Germline APC Loss of Function
|
| Familial Nonmedullary Thyroid Carcinoma | causative germline | |
| Small Intestine Cancer | risk factor |
mechanism: Adenoma-Carcinoma Sequence and Wnt-APC Activation
subtype: Adenocarcinoma
|
| Classic Familial Adenomatous Polyposis |
untyped
Germline pathogenic loss-of-function variants
|
mechanism: APC promoter 1B-dependent allelic silencing; Germline APC loss-of-function predisposition; Somatic APC Second-Hit Inactivation (Knudson Two-Hit)
|
| Colon Adenocarcinoma |
untyped
Somatic loss of function
|
|
| Familial Adenomatous Polyposis |
untyped
Germline Loss-of-Function Mutations
|
|
| Hepatoblastoma |
untyped
Germline Predisposition
|
|
| Medulloblastoma, WNT-Activated |
untyped
Germline/Somatic Mutation
|
|
| MBD4-Related Tumor Predisposition Syndrome | no genetic record somatic loss of function |
mechanism: Somatic APC Inactivation by CpG>TpG Transition
|
| MUTYH-Associated Polyposis | no genetic record somatic loss of function |
mechanism: Somatic APC Inactivation by Transversion
|
| Thymic Neuroendocrine Carcinoma | no genetic record |
mechanism: Chromatin Regulator Loss
|
An entry matches when ClinGen's MONDO disease is the entry's own disease term, a subtype term, or an exact-match mapping. An amber status marks an entry ClinGen supports the gene for (Definitive, Strong or Moderate) whose own record does not type it. A Limited, Disputed or Refuted tier on such an entry is not a gap.
| ClinGen disease | MOI | Classification | dismech entry |
|---|---|---|---|
| gastric adenocarcinoma and proximal polyposis of the stomach MONDO:0017790 | AD | Definitive 2022-06-20 |
no dismech entry |
| classic or attenuated familial adenomatous polyposis MONDO:0021057 | AD | Definitive 2022-06-20 |
no dismech entry |
Identity from HGNC (snapshot 2026-10-01). Page layers are described in the gene pages documentation.